Filtros de búsqueda

Lista de obras de Felicitas Genze

A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells

artículo científico publicado en 2015

Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer

artículo científico publicado en 2013

Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).

artículo científico publicado en 2016

Comparison of In Vitro- and Chorioallantoic Membrane (CAM)-Culture Systems for Cryopreserved Medulla-Contained Human Ovarian Tissue

artículo científico publicado el 30 de marzo de 2012

HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization

artículo científico publicado en 2014

High-resolution MRI analysis of breast cancer xenograft on the chick chorioallantoic membrane

artículo científico publicado en 2015

Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity

artículo científico publicado en 2005

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer

artículo científico publicado en 2011

PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation

artículo científico publicado en 2016

Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours

artículo científico publicado en 2010

Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma

artículo científico publicado en 2009

Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells

artículo científico publicado en 2014

Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo

artículo científico publicado en 2008

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33

artículo científico publicado el 26 de marzo de 2012